India, Sept. 16 -- Ginkgo Bioworks (DNA) announced that its Ginkgo Datapoints offering has entered into a new agreement with Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly and Company.
Under the agreement, Ginkgo Datapoints will provide discovery data generation services, including small molecule developability testing and antibody developability testing, to biotech companies participating in TuneLab.
The collaboration is designed to connect AI-generated drug discovery hypotheses with experimental laboratory data, allowing TuneLab participants to generate standardized, machine-learning-ready datasets for use with predictive models.
Ginkgo's automated laboratories are expected to enable TuneLab companies to conduct e...